Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.
Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D.
Mohyuddin GR, et al.
Blood Cancer J. 2022 Dec 16;12(12):168. doi: 10.1038/s41408-022-00769-4.
Blood Cancer J. 2022.
PMID: 36526617
Free PMC article.
No abstract available.